icon-folder.gif   Conference Reports for NATAP  
 
  15th International Workshop on
Clinical Pharmacology
of HIV and Hepatitis Therapy
May 19- 21, 2014, Washington, DC
Back grey_arrow_rt.gif
 
 
 
Thorough QT/QTc Trial to Evaluate the Effect of the HIV-1 Attachment Inhibitor BMS-626529, Administered as its Prodrug, BMS-663068, on QTc Intervals
 
 
  Reported by Jules Levin
15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 19-21 May 2014, Washington DC, USA
 
Hruska MW, Savant IA, Anderson JA, Shah V, Chang I, Adamczyk R, Furlong M, Hanna GJ, Bertz R, Zhu L
Bristol-Myers Squibb, Princeton, NJ, USA

Pharm1.gif

Pharm2.gif

Pharm3.gif

Pharm4.gif

Pharm5.gif

Pharm6.gif

Pharm7.gif

Pharm8.gif

Pharm9.gif

Pharm10.gif

Pharm11.gif

Pharm12.gif

Pharm13.gif